Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
Daniel Chauss(National Institute of Diabetes and Digestive and Kidney Diseases), Behdad Afzali(National Institutes of Health)
Cited by 202
Related Papers
Developing in vitro expanded CD45RA<sup>+</sup>regulatory T cells as an adoptive cell therapy for Crohn's disease
|Gut|2015|194
Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
|Frontiers in Immunology|2013|88
An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|32